18-78992096-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_171999.4(SALL3):āc.105G>Cā(p.Glu35Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000511 in 1,565,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_171999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SALL3 | NM_171999.4 | c.105G>C | p.Glu35Asp | missense_variant | 2/3 | ENST00000537592.7 | NP_741996.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SALL3 | ENST00000537592.7 | c.105G>C | p.Glu35Asp | missense_variant | 2/3 | 5 | NM_171999.4 | ENSP00000441823 | P1 | |
SALL3 | ENST00000575389.6 | c.105G>C | p.Glu35Asp | missense_variant | 2/4 | 5 | ENSP00000458360 | |||
SALL3 | ENST00000536229.7 | c.-295G>C | 5_prime_UTR_variant | 1/3 | 3 | ENSP00000439975 | ||||
SALL3 | ENST00000572928.1 | n.84G>C | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000158 AC: 3AN: 189530Hom.: 0 AF XY: 0.0000292 AC XY: 3AN XY: 102830
GnomAD4 exome AF: 0.00000354 AC: 5AN: 1413116Hom.: 0 Cov.: 29 AF XY: 0.00000430 AC XY: 3AN XY: 698266
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at